//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
ProfilePosts









Loading...
This week, the House Appropriations Committee passed the FY27 Labor-HHS bill, funding key agencies like NIH & CDC. Now Congress must go further: provide higher levels of funding & reject harmful administration proposals. Take action: https://ow.ly/o4Zy50ZbaLE #Fight4Hematology #HemeSky
9h
American Society of Hematology
How does extracellular sickle hemoglobin contribute to liver damage? Join this month's Journal Club to explore the cellular pathways involved and potential therapeutic implications. https://ow.ly/bJpM50Z9vW0 #HemeSky #ConquerSCD Blood Journals Portfolio
2d
šŸ“¢ Reminder: CRTI applications are open! Fellows & early- to mid-career #hematology faculty in Latin America, Asia-Pacific, & MMENA can apply for training in clinical trial design, patient-oriented research, mentorship, & more! Apply now! šŸ”— https://ow.ly/8IuA50Z9xPC #ASHTrainee #HemeSky #MedSky
Will you be at #EHA26? Be sure to stop by the ASH Booth (A4.05)! Meet the ASH team, explore resources, and meet the Blood Journals editors. See you there! 🩸 #HemeSky
ASH is heading to #EHA26! Visit Booth A4.05 to explore resources and meet the Blood Journals editors. 🩸 #HemeSky
3d
8d
4d
New research published in Blood found that stem cell transplantation was the most cost-effective treatment option for adults living with sickle cell disease compared with gene therapy and standard of care. Read more šŸ”— https://ow.ly/eiQj50Z7aPU #HemeSky #ConquerSCD Blood Journals Portfolio
Abstract submissions are now open for #ASH26! Your research could shape future discoveries, influence the care of patients, and drive breakthroughs in hematology. Share your work at the 68th ASH Annual Meeting and Exposition. šŸ”— https://ow.ly/UfL450Z6EZ9 #HemeSky #MedSky
How is frontline immunosuppressive therapy for aplastic anemia evolving in 2026? Join the next Aplastic Anemia Clinical Case Webinar focusing on highlights from #EHA2026 and practical, evidence-based strategies for patient management. Register now: https://ow.ly/MGah50ZbipY
Two new studies examining whether the time of day of CAR-T infusion influences outcomes in relapsed/refractory large B-cell lymphoma arrive at divergent conclusions. Read more in The Hematologist: https://ow.ly/QpaS50Z5yJs #HemeOnc #Hematology #HemeSky #MedSky
ASH has announced new names for several honorific awards recognizing pioneers whose work transformed #hematology through research, mentorship, equity, and clinical care. Learn more in ASH Clinical News: https://ow.ly/6B3n50Z8LuX #ASHAwards #HemeSky
American Society of Hematology
9d
10d
5h
1d
4d
American Society of Hematology
American Society of Hematology
American Society of Hematology
American Society of Hematology
American Society of Hematology
American Society of Hematology
American Society of Hematology
American Society of Hematology